Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. More Details
Excellent balance sheet with weak fundamentals.
Share Price & News
How has Health Discovery's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HDVY's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: HDVY underperformed the US Healthcare industry which returned 17.9% over the past year.
Return vs Market: HDVY underperformed the US Market which returned 12% over the past year.
Price Volatility Vs. Market
How volatile is Health Discovery's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Health Discovery undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate HDVY's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate HDVY's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: HDVY is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: HDVY is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HDVY's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HDVY is overvalued based on its PB Ratio (16.4x) compared to the US Healthcare industry average (2.7x).
How is Health Discovery forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Health Discovery has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Health Discovery's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Health Discovery's filings and announcementshere.
- Explore growth companies in the Healthcare industry.
How has Health Discovery performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HDVY is currently unprofitable.
Growing Profit Margin: HDVY is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: HDVY is unprofitable, but has reduced losses over the past 5 years at a rate of 27.5% per year.
Accelerating Growth: Unable to compare HDVY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HDVY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).
Return on Equity
High ROE: HDVY has a negative Return on Equity (-47.84%), as it is currently unprofitable.
How is Health Discovery's financial position?
Financial Position Analysis
Short Term Liabilities: HDVY's short term assets ($1.7M) exceed its short term liabilities ($648.0K).
Long Term Liabilities: HDVY has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: HDVY's debt to equity ratio (20.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if HDVY's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HDVY has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: HDVY has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 38.6% each year.
What is Health Discovery current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HDVY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HDVY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HDVY's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HDVY's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HDVY's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
George McGovern (73 yo)
Mr. George H. McGovern, III, has been the Chairman and Chief Executive Officer of Health Discovery Corporation since February 24, 2017. Mr. McGovern is a Co-Founder, Chairman and Chief Executive Officer at ...
CEO Compensation Analysis
Compensation vs Market: George's total compensation ($USD154.41K) is below average for companies of similar size in the US market ($USD606.53K).
Compensation vs Earnings: George's compensation has been consistent with company performance over the past year.
|Chairman & CEO||3.58yrs||US$154.41k||20.07% |
|Independent Director||3.42yrs||US$147.14k||0.99% |
|Member of the Scientific Advisory Board||16.83yrs||no data||no data|
|Member of the Scientific Advisory Board||no data||no data||no data|
|Member of Scientific Advisory Board||no data||US$120.00k||no data|
|Member of the Scientific Advisory Board||16.17yrs||no data||no data|
|Member of Scientific Advisory Board||16.17yrs||no data||no data|
|Independent Director||3.42yrs||US$147.14k||2.6% |
|Independent Director||2.33yrs||US$147.14k||0.99% |
Experienced Board: HDVY's board of directors are considered experienced (3.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.8%.
Health Discovery Corporation's company bio, employee growth, exchange listings and data sources
- Name: Health Discovery Corporation
- Ticker: HDVY
- Exchange: OTCPK
- Founded: 2001
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$13.333m
- Shares outstanding: 404.04m
- Website: https://www.healthdiscoverycorp.com
Number of Employees
- Health Discovery Corporation
- 2002 Summit Boulevard, NE
- Suite 300
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|HDVY||OTCPK (Pink Sheets LLC)||Yes||Common Stock||US||USD||Nov 2001|
Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United St ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/26 06:32|
|End of Day Share Price||2020/09/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.